What does MIRA Pharmaceuticals, Inc. do?
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator,…
What is MIRA Pharmaceuticals, Inc.'s P/E and P/B ratio?
MIRA Pharmaceuticals, Inc. has a P/E ratio of -0.6 and a P/B ratio of 3.24.
What is MIRA Pharmaceuticals, Inc.'s debt-to-equity ratio?
MIRA Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.00.
How much does MIRA Pharmaceuticals, Inc. owe compared with what it owns?
MIRA Pharmaceuticals, Inc. owes $0.01 for every $1 it owns (balance sheet Jun 2026), which is low.
What is MIRA Pharmaceuticals, Inc.'s Positivity rank?
MIRA Pharmaceuticals, Inc. is ranked #3,966 of 6,774 companies globally and #1,866 of 4,000 in United States on PositoAI, with a Positivity Score of 20,052.
Does MIRA Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. MIRA Pharmaceuticals, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 31 Jul 2026). It has no yellow flags.
Where can I read the latest news about MIRA Pharmaceuticals, Inc.?
Recent headlines about MIRA Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does MIRA Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of MIRA Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.